Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008738:Methyl Ethers / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011799:Quinazolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000959:Antihypertensive Agents; D008738:Methyl Ethers; D010879:Piperazines; D010919:Placebos; D011799:Quinazolines; D008750:Methyldopa